Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction
Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study
The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Evaluation of a provocative dyspnea severity score in acute heart failure
Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?
Computer-guided normal-low versus normal-high potassium control after cardiac surgery: No impact on atrial fibrillation or atrial flutter
Trends in hospitalization for takotsubo cardiomyopathy in the United States
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute–Bristol-Myers Squibb Supporting Open Access to Researchers Initiative
Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel
Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables
A ggressive hydra T ion in patients with S T-E levation M yocardial infarction undergoing P rimary percutaneous coronary intervention to preven T contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for RE duction of contra S t-indu C ed nephropathy follow IN g car D iac catheterization) trial
Design and rationale of the HITTS randomized controlled trial: Effect of H igh-intensity Interval T raining in de novo Heart T ransplant Recipients in S candinavia
Adjunctive anticoagulation during peripheral vascular intervention
Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis
Thrombus aspiration in patients with large anterior myocardial infarction
Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial
Untangling the paradox: Obesity as prognostic marker in prevalent cardiovascular disease
Excess weight and life expectancy after acute myocardial infarction: The obesity paradox reexamined
Automatic external defibrillator–only resuscitation in cardiac arrest? The approach may be shocking!
Employment and residential characteristics in relation to automated external defibrillator locations
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients
Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” ( Am Heart J. 2015;170[4]:627-634)